Annual EBIT
-$40.49 M
+$9.30 M+18.68%
01 June 2022
Summary:
Pluristem Therapeutics annual earnings before interest & taxes is currently -$40.49 million, with the most recent change of +$9.30 million (+18.68%) on 01 June 2022. During the last 3 years, it has risen by +$9.30 million (+18.68%).PSTI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$6.08 M
+$2.80 M+31.53%
01 September 2022
Summary:
Pluristem Therapeutics quarterly earnings before interest & taxes is currently -$6.08 million, with the most recent change of +$2.80 million (+31.53%) on 01 September 2022.PSTI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$35.38 M
+$5.13 M+12.66%
01 September 2022
Summary:
Pluristem Therapeutics TTM earnings before interest & taxes is currently -$35.38 million, with the most recent change of +$5.13 million (+12.66%) on 01 September 2022.PSTI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +18.7% | +45.8% | +32.5% |
| 5 y5 years | -14.7% | +15.6% | -5.5% |
PSTI EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | >+9999.0% | >+9999.0% | >+9999.0% |
Pluristem Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$6.08 M(-31.5%) | -$35.38 M(-12.7%) |
| June 2022 | -$40.49 M(-18.7%) | -$8.87 M(-9.4%) | -$40.51 M(-12.5%) |
| Mar 2022 | - | -$9.80 M(-7.9%) | -$46.30 M(-8.5%) |
| Dec 2021 | - | -$10.64 M(-5.0%) | -$50.61 M(-3.4%) |
| Sept 2021 | - | -$11.20 M(-23.6%) | -$52.40 M(+5.6%) |
| June 2021 | -$49.79 M(+68.9%) | -$14.66 M(+4.0%) | -$49.63 M(+14.1%) |
| Mar 2021 | - | -$14.10 M(+13.5%) | -$43.48 M(+18.2%) |
| Dec 2020 | - | -$12.43 M(+47.3%) | -$36.78 M(+19.7%) |
| Sept 2020 | - | -$8.44 M(-0.9%) | -$30.72 M(+4.2%) |
| June 2020 | -$29.48 M(-16.5%) | -$8.51 M(+15.1%) | -$29.48 M(+2.8%) |
| Mar 2020 | - | -$7.40 M(+16.2%) | -$28.67 M(-9.2%) |
| Dec 2019 | - | -$6.37 M(-11.5%) | -$31.57 M(-5.9%) |
| Sept 2019 | - | -$7.20 M(-6.6%) | -$33.53 M(-5.0%) |
| June 2019 | -$35.31 M(+35.1%) | -$7.71 M(-25.2%) | -$35.31 M(+22.7%) |
| Mar 2019 | - | -$10.30 M(+23.6%) | -$28.77 M(+4.5%) |
| Dec 2018 | - | -$8.33 M(-7.1%) | -$27.52 M(-0.5%) |
| Sept 2018 | - | -$8.97 M(+666.0%) | -$27.66 M(+5.9%) |
| June 2018 | -$26.13 M(-6.8%) | -$1.17 M(-87.1%) | -$26.13 M(-17.2%) |
| Mar 2018 | - | -$9.05 M(+6.9%) | -$31.54 M(+2.7%) |
| Dec 2017 | - | -$8.47 M(+13.8%) | -$30.72 M(+6.3%) |
| Sept 2017 | - | -$7.44 M(+13.0%) | -$28.90 M(+3.1%) |
| June 2017 | -$28.02 M(+20.2%) | -$6.59 M(-19.9%) | -$28.02 M(+1.5%) |
| Mar 2017 | - | -$8.22 M(+23.7%) | -$27.61 M(+3.1%) |
| Dec 2016 | - | -$6.65 M(+1.3%) | -$26.78 M(+9.9%) |
| Sept 2016 | - | -$6.56 M(+6.3%) | -$24.36 M(+4.5%) |
| June 2016 | -$23.32 M(-7.7%) | -$6.17 M(-16.5%) | -$23.32 M(+1.6%) |
| Mar 2016 | - | -$7.39 M(+74.9%) | -$22.96 M(-0.6%) |
| Dec 2015 | - | -$4.23 M(-23.4%) | -$23.09 M(-8.2%) |
| Sept 2015 | - | -$5.52 M(-5.0%) | -$25.17 M(-0.4%) |
| June 2015 | -$25.27 M(-9.3%) | -$5.81 M(-22.8%) | -$25.27 M(-3.4%) |
| Mar 2015 | - | -$7.53 M(+19.5%) | -$26.17 M(-6.3%) |
| Dec 2014 | - | -$6.30 M(+12.1%) | -$27.92 M(-2.4%) |
| Sept 2014 | - | -$5.62 M(-16.2%) | -$28.61 M(+2.7%) |
| June 2014 | -$27.85 M(+25.3%) | -$6.71 M(-27.7%) | -$27.85 M(-1.8%) |
| Mar 2014 | - | -$9.29 M(+32.9%) | -$28.35 M(+13.4%) |
| Dec 2013 | - | -$6.99 M(+43.8%) | -$25.00 M(+9.2%) |
| Sept 2013 | - | -$4.86 M(-32.6%) | -$22.89 M(+3.0%) |
| June 2013 | -$22.22 M(+47.8%) | -$7.22 M(+21.6%) | -$22.22 M(+17.1%) |
| Mar 2013 | - | -$5.93 M(+21.5%) | -$18.98 M(+7.5%) |
| Dec 2012 | - | -$4.88 M(+16.6%) | -$17.66 M(+18.6%) |
| Sept 2012 | - | -$4.19 M(+5.5%) | -$14.89 M(-0.9%) |
| June 2012 | -$15.03 M | -$3.97 M(-13.9%) | -$15.03 M(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$4.61 M(+117.7%) | -$14.62 M(+15.0%) |
| Dec 2011 | - | -$2.12 M(-51.1%) | -$12.71 M(-5.3%) |
| Sept 2011 | - | -$4.33 M(+21.8%) | -$13.41 M(+23.8%) |
| June 2011 | -$10.84 M(+45.7%) | -$3.56 M(+31.8%) | -$10.84 M(+20.4%) |
| Mar 2011 | - | -$2.70 M(-4.4%) | -$9.00 M(+5.2%) |
| Dec 2010 | - | -$2.82 M(+61.0%) | -$8.56 M(+13.3%) |
| Sept 2010 | - | -$1.75 M(+1.9%) | -$7.55 M(-9.0%) |
| June 2010 | -$7.44 M(+13.4%) | -$1.72 M(-23.8%) | -$8.30 M(+1.0%) |
| Mar 2010 | - | -$2.26 M(+23.9%) | -$8.22 M(+4.4%) |
| Dec 2009 | - | -$1.82 M(-27.2%) | -$7.88 M(+14.7%) |
| Sept 2009 | - | -$2.50 M(+52.8%) | -$6.87 M(+4.7%) |
| June 2009 | -$6.56 M(-37.1%) | -$1.64 M(-14.2%) | -$6.56 M(-14.2%) |
| Mar 2009 | - | -$1.91 M(+134.9%) | -$7.64 M(-9.9%) |
| Dec 2008 | - | -$813.00 K(-63.0%) | -$8.48 M(-17.1%) |
| Sept 2008 | - | -$2.20 M(-19.4%) | -$10.23 M(-1.9%) |
| June 2008 | -$10.43 M(+66.2%) | -$2.72 M(-0.9%) | -$10.43 M(-1.7%) |
| Mar 2008 | - | -$2.75 M(+7.3%) | -$10.60 M(+8.0%) |
| Dec 2007 | - | -$2.56 M(+7.0%) | -$9.82 M(+24.7%) |
| Sept 2007 | - | -$2.39 M(-17.4%) | -$7.87 M(+25.5%) |
| June 2007 | -$6.28 M(+169.1%) | -$2.90 M(+47.5%) | -$6.28 M(+50.3%) |
| Mar 2007 | - | -$1.97 M(+219.5%) | -$4.17 M(+48.5%) |
| Dec 2006 | - | -$615.00 K(-22.7%) | -$2.81 M(+5.4%) |
| Sept 2006 | - | -$796.00 K(-0.3%) | -$2.67 M(+14.3%) |
| June 2006 | -$2.33 M(-12.4%) | -$798.30 K(+32.8%) | -$2.33 M(+14.8%) |
| Mar 2006 | - | -$601.10 K(+27.7%) | -$2.03 M(-24.9%) |
| Dec 2005 | - | -$470.60 K(+1.8%) | -$2.70 M(+2.1%) |
| Sept 2005 | - | -$462.20 K(-7.2%) | -$2.65 M(-0.5%) |
| June 2005 | -$2.66 M(-67.9%) | -$497.80 K(-60.9%) | -$2.66 M(-69.2%) |
| Mar 2005 | - | -$1.27 M(+206.4%) | -$8.64 M(+1.6%) |
| Dec 2004 | - | -$415.50 K(-12.5%) | -$8.50 M(+0.7%) |
| Sept 2004 | - | -$474.70 K(-92.7%) | -$8.44 M(+1.9%) |
| June 2004 | -$8.28 M(+3834.9%) | -$6.47 M(+469.2%) | -$8.28 M(+319.0%) |
| Mar 2004 | - | -$1.14 M(+218.4%) | -$1.98 M(+133.5%) |
| Dec 2003 | - | -$357.10 K(+12.7%) | -$846.70 K(+66.1%) |
| Sept 2003 | - | -$316.90 K(+91.1%) | -$509.60 K(+142.0%) |
| June 2003 | -$210.50 K(+182.6%) | -$165.80 K(+2302.9%) | -$210.60 K(+212.9%) |
| Mar 2003 | - | -$6900.00(-65.5%) | -$67.30 K(-15.5%) |
| Dec 2002 | - | -$20.00 K(+11.7%) | -$79.60 K(+8.9%) |
| Sept 2002 | - | -$17.90 K(-20.4%) | -$73.10 K(+32.4%) |
| June 2002 | -$74.50 K | -$22.50 K(+17.2%) | -$55.20 K(+68.8%) |
| Mar 2002 | - | -$19.20 K(+42.2%) | -$32.70 K(+142.2%) |
| Dec 2001 | - | -$13.50 K | -$13.50 K |
FAQ
- What is Pluristem Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Pluristem Therapeutics?
- What is Pluristem Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Pluristem Therapeutics?
What is Pluristem Therapeutics annual earnings before interest & taxes?
The current annual EBIT of PSTI is -$40.49 M
What is the all time high annual EBIT for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual earnings before interest & taxes is -$74.50 K
What is Pluristem Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of PSTI is -$6.08 M
What is the all time high quarterly EBIT for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly earnings before interest & taxes is -$6900.00
What is Pluristem Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of PSTI is -$35.38 M
What is the all time high TTM EBIT for Pluristem Therapeutics?
Pluristem Therapeutics all-time high TTM earnings before interest & taxes is -$13.50 K